Pacific Biosciences of California, Inc. Operating Cash Flow
Pacific Biosciences of California, Inc. (PACB) reported Operating Cash Flow of -$80.27 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- Pacific Biosciences of California, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$35.58M.
- Pacific Biosciences of California, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$44.69M.
- Pacific Biosciences of California, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$19.07M.
- Pacific Biosciences of California, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$18.71M.
- Pacific Biosciences of California, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$111.21M.
- Pacific Biosciences of California, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$206.06M.
- Pacific Biosciences of California, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$259.17M.
- Pacific Biosciences of California, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$263.21M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$35.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$80.27M 10-Q · filed 2026-08-06 | -$99.34M derived: sum of 3 quarters · filed 2026-08-06 | -$118.05M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$44.69M 10-Q · filed 2026-05-08 | -$63.76M derived: sum of 2 quarters · filed 2026-05-08 | -$82.47M derived: sum of 3 quarters · filed 2026-05-08 | -$111.84M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$19.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$37.78M derived: sum of 2 quarters · filed 2026-02-25 | -$67.15M derived: sum of 3 quarters · filed 2026-08-06 | -$111.21M 10-K · filed 2026-02-25 |
| 2025-09-30 | -$18.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$48.08M derived: sum of 2 quarters · filed 2026-08-06 | -$92.14M 10-Q · filed 2025-11-06 | -$122.79M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$29.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$73.43M 10-Q · filed 2026-08-06 | -$104.08M derived: sum of 3 quarters · filed 2026-08-06 | -$149.55M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$44.06M 10-Q · filed 2026-05-08 | -$74.71M derived: sum of 2 quarters · filed 2026-05-08 | -$120.17M derived: sum of 3 quarters · filed 2026-05-08 | -$174.43M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$30.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$76.11M derived: sum of 2 quarters · filed 2026-02-25 | -$130.38M derived: sum of 3 quarters · filed 2026-02-25 | -$206.06M 10-K · filed 2026-02-25 |
| 2024-09-30 | -$45.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$99.73M derived: sum of 2 quarters · filed 2025-11-06 | -$175.41M 10-Q · filed 2025-11-06 | -$232.97M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | -$54.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$129.94M 10-Q · filed 2025-08-07 | -$187.50M derived: sum of 3 quarters · filed 2026-02-25 | -$252.69M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | -$75.68M 10-Q · filed 2025-05-12 | -$133.24M derived: sum of 2 quarters · filed 2026-02-25 | -$198.42M derived: sum of 3 quarters · filed 2026-02-25 | -$240.16M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | -$57.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$122.74M derived: sum of 2 quarters · filed 2026-02-25 | -$164.48M derived: sum of 3 quarters · filed 2026-02-25 | -$259.17M 10-K · filed 2026-02-25 |
| 2023-09-30 | -$65.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$106.92M derived: sum of 2 quarters · filed 2024-11-12 | -$201.61M 10-Q · filed 2024-11-12 | -$262.18M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-06-30 | -$41.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$136.43M 10-Q · filed 2024-08-09 | -$197.00M derived: sum of 3 quarters · filed 2025-03-17 | -$260.05M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-03-31 | -$94.69M 10-Q · filed 2024-05-09 | -$155.26M derived: sum of 2 quarters · filed 2025-03-17 | -$218.31M derived: sum of 3 quarters · filed 2025-03-17 | -$278.87M derived: sum of 4 quarters · filed 2025-03-17 |
| 2022-12-31 | -$60.57M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | -$123.62M derived: sum of 2 quarters · filed 2025-03-17 | -$184.18M derived: sum of 3 quarters · filed 2025-03-17 | -$263.21M 10-K · filed 2025-03-17 |
| 2022-09-30 | -$63.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$123.62M derived: sum of 2 quarters · filed 2023-11-03 | -$202.65M 10-Q · filed 2023-11-03 | -$234.35M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | -$60.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$139.59M 10-Q · filed 2023-08-04 | -$171.30M derived: sum of 3 quarters · filed 2024-02-28 | -$211.96M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | -$79.03M 10-Q · filed 2023-05-04 | -$110.74M derived: sum of 2 quarters · filed 2024-02-28 | -$151.39M derived: sum of 3 quarters · filed 2024-02-28 | -$167.10M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | -$31.71M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$72.36M derived: sum of 2 quarters · filed 2024-02-28 | -$88.08M derived: sum of 3 quarters · filed 2024-02-28 | -$111.18M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$40.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$56.37M derived: sum of 2 quarters · filed 2022-11-08 | -$79.47M 10-Q · filed 2022-11-08 | -$93.73M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | -$15.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$38.82M 10-Q · filed 2022-08-08 | -$53.08M derived: sum of 3 quarters · filed 2023-02-28 | -$70.89M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$23.10M 10-Q · filed 2022-05-06 | -$37.37M derived: sum of 2 quarters · filed 2023-02-28 | -$55.17M derived: sum of 3 quarters · filed 2023-02-28 | -$78.96M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$14.26M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$32.07M derived: sum of 2 quarters · filed 2023-02-28 | -$55.86M derived: sum of 3 quarters · filed 2023-02-28 | $19.50M 10-K · filed 2023-02-28 |
| 2020-09-30 | -$17.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | -$41.60M derived: sum of 2 quarters · filed 2021-11-05 | $33.77M 10-Q · filed 2021-11-05 | $15.59M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | -$23.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $51.57M 10-Q · filed 2021-08-06 | $33.39M derived: sum of 3 quarters · filed 2022-02-28 | $16.13M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $75.36M 10-Q · filed 2021-05-06 | $57.18M derived: sum of 2 quarters · filed 2022-02-28 | $39.92M derived: sum of 3 quarters · filed 2022-02-28 | $22.36M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | -$18.18M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$35.44M derived: sum of 2 quarters · filed 2022-02-28 | -$53.00M derived: sum of 3 quarters · filed 2022-02-28 | -$78.31M 10-K · filed 2022-02-28 |
| 2019-09-30 | -$17.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | -$34.82M derived: sum of 2 quarters · filed 2020-11-03 | -$60.13M 10-Q · filed 2020-11-03 | -$79.12M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | -$17.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$42.87M 10-Q · filed 2020-08-06 | -$61.86M derived: sum of 3 quarters · filed 2021-02-26 | -$76.03M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | -$25.31M 10-Q · filed 2020-05-08 | -$44.30M derived: sum of 2 quarters · filed 2021-02-26 | -$58.47M derived: sum of 3 quarters · filed 2021-02-26 | -$72.97M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | -$18.98M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | -$33.16M derived: sum of 2 quarters · filed 2021-02-26 | -$47.66M derived: sum of 3 quarters · filed 2021-02-26 | -$66.43M 10-K · filed 2021-02-26 |
| 2018-09-30 | -$14.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$28.67M derived: sum of 2 quarters · filed 2019-11-07 | -$47.45M 10-Q · filed 2019-11-07 | -$67.64M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | -$14.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$33.27M 10-Q · filed 2019-08-06 | -$53.47M derived: sum of 3 quarters · filed 2020-02-28 | -$71.31M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | -$18.77M 10-Q · filed 2019-05-03 | -$38.97M derived: sum of 2 quarters · filed 2020-02-28 | -$56.81M derived: sum of 3 quarters · filed 2020-02-28 | -$69.62M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | -$20.20M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | -$38.04M derived: sum of 2 quarters · filed 2020-02-28 | -$50.85M derived: sum of 3 quarters · filed 2020-02-28 | -$67.52M 10-K · filed 2020-02-28 |
| 2017-09-30 | -$17.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | -$30.65M derived: sum of 2 quarters · filed 2018-11-05 | -$47.32M 10-Q · filed 2018-11-05 | |
| 2017-06-30 | -$12.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | -$29.48M 10-Q · filed 2018-08-03 | ||
| 2017-03-31 | -$16.67M 10-Q · filed 2018-05-02 | |||
| 2016-12-31 | -$67.93M 10-K · filed 2019-02-26 | |||
| 2014-03-31 | -$16.26M 10-Q · filed 2014-05-08 | -$30.83M derived: sum of 2 quarters · filed 2014-05-08 | -$12.11M derived: sum of 3 quarters · filed 2014-05-08 | -$28.51M derived: sum of 4 quarters · filed 2014-05-08 |
| 2013-12-31 | -$14.57M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $4.15M derived: sum of 2 quarters · filed 2014-03-14 | -$12.26M derived: sum of 3 quarters · filed 2014-03-14 | -$29.83M 10-K · filed 2014-03-14 |
| 2013-09-30 | $18.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $2.32M derived: sum of 2 quarters · filed 2013-11-12 | -$15.26M 10-Q · filed 2013-11-12 | -$33.48M derived: sum of 4 quarters · filed 2014-05-08 |
| 2013-06-30 | -$16.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$33.98M 10-Q · filed 2013-08-09 | -$52.20M derived: sum of 3 quarters · filed 2014-05-08 | -$69.85M derived: sum of 4 quarters · filed 2014-05-08 |
| 2013-03-31 | -$17.57M 10-Q · filed 2014-05-08 | -$35.80M derived: sum of 2 quarters · filed 2014-05-08 | -$53.45M derived: sum of 3 quarters · filed 2014-05-08 | -$77.06M derived: sum of 4 quarters · filed 2014-05-08 |
| 2012-12-31 | -$18.22M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | -$35.87M derived: sum of 2 quarters · filed 2014-03-14 | -$59.48M derived: sum of 3 quarters · filed 2014-03-14 | -$76.82M 10-K · filed 2014-03-14 |
| 2012-09-30 | -$17.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$41.26M derived: sum of 2 quarters · filed 2013-11-12 | -$58.60M 10-Q · filed 2013-11-12 | -$73.37M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-06-30 | -$23.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$40.95M 10-Q · filed 2013-08-09 | -$55.72M derived: sum of 3 quarters · filed 2014-03-14 | -$79.57M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-03-31 | -$17.34M 10-Q · filed 2013-05-10 | -$32.11M derived: sum of 2 quarters · filed 2014-03-14 | -$55.96M derived: sum of 3 quarters · filed 2014-03-14 | -$86.85M derived: sum of 4 quarters · filed 2014-03-14 |
| 2011-12-31 | -$14.77M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | -$38.62M derived: sum of 2 quarters · filed 2014-03-14 | -$69.52M derived: sum of 3 quarters · filed 2014-03-14 | -$102.97M 10-K · filed 2014-03-14 |
| 2011-09-30 | -$23.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | -$54.74M derived: sum of 2 quarters · filed 2012-11-01 | -$88.20M 10-Q · filed 2012-11-01 | -$127.25M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-06-30 | -$30.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | -$64.35M 10-Q · filed 2012-08-07 | -$103.40M derived: sum of 3 quarters · filed 2013-03-15 | -$136.75M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-03-31 | -$33.46M 10-Q · filed 2012-05-07 | -$72.50M derived: sum of 2 quarters · filed 2013-03-15 | -$105.86M derived: sum of 3 quarters · filed 2013-03-15 | |
| 2010-12-31 | -$39.05M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | -$72.40M derived: sum of 2 quarters · filed 2013-03-15 | -$122.00M 10-K · filed 2013-03-15 | |
| 2010-09-30 | -$33.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | -$82.95M 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | -$49.59M 10-Q · filed 2011-08-12 | |||
| 2009-12-31 | -$74.84M 10-K · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |